C0282574||RNActiveÂ® Technology
C1171370||Testing
C0003320||Immunogenic
C0035696||mRNA
C0042210||Vaccines
C0035696||mRNA
C0042210||vaccines
C2256030||immune stimulation
C1171370||testing
C1622984||production
C0035696||mRNA
C3714634||immunogenicity
C0028630||nucleotides
C0162327||mRNA sequence
C0033603||nucleotide-binding peptide protamine
C0033603||protamine
C0035696||mRNA
C0042210||vaccines
C1515655||in vivo
C0220825||evaluation
C0042210||vaccine
C4277607||immunogenicity